Brokerages Set Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Target Price at $505.57
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the stock, Marketbeat reports. Ten investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to […]
Shares of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX – Get Free Report) have earned an average recommendation of “Moderate Buy” from the twenty-six brokerages that are covering the stock, Marketbeat reports. Ten investment analysts have rated the stock with a hold rating, fifteen have given a buy rating and one has assigned a strong buy rating to […]
